Table 1 Patient characteristics
Survivor | Non-survivor | p-value | |||
|---|---|---|---|---|---|
n = 191 | n = 31 | ||||
Demographics | |||||
Age (years) | 68 (56 to 78) | 71 (60 to 79) | 0.34 | ||
Male | 115 (60.2) | 19 (61.3) | 0.91 | ||
Underlying disease types | 0.25 | ||||
Hematopoietic disorders | 71 (64.5) | 11 (35.5) | |||
Infectious diseases | 77 (71.0) | 9 (29.0) | |||
The others | 43 (64.5) | 11 (35.5) | |||
Laboratory tests | |||||
Platelets (× 103/µL) | 69 (40 to 164) | 39 (14 to 128) | 0.006 | ||
FDP (µg/mL) | 22.05 (11.5 to 44.7) | 22.72 (13.7 to 116.7) | 0.19 | ||
D-dimer (µg/mL) | 14.6 (8.5 to 28.0) | 13.0 (8.5 to 70.0) | 0.68 | ||
PT-INR | 1.2 (1.05 to 1.41) | 1.4 (1.2 to 1.54) | 0.003 | ||
Fibrinogen (mg/dL) | 270 (186 to 422) | 212 (128 to 282) | 0.013 | ||
AT (%) | 85.8 (67.8 to 101.9) | 74.8 (59.3 to 88.5) | 0.013 | ||
TAT* (ng/mL) | 10.85 (6.09 to 30.7) | 32.18 (11 to 145.73) | < 0.001 | ||
SF (µg/mL) | 43.4 (18.1 to 103) | 52.9 (17.5 to 215) | 0.23 | ||
F1 + 2† (pmol/L) | 748 (416 to 1201) | 849.5 (324 to1201) | 0.99 | ||
Liver failure | NA | 1 (3.2) | NA | ||
Anti-DIC agents | |||||
rhTM | 81 (42.6) | 21 (67.7) | 0.009 | ||
Antithrombin | 39 (20.5) | 11 (35.5) | 0.065 | ||